Adirondack Trust Company’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10
Closed -$2K 491
2022
Q3
$2K Hold
10
﹤0.01% 453
2022
Q2
$2K Hold
10
﹤0.01% 431
2022
Q1
$3K Hold
10
﹤0.01% 401
2021
Q4
$4K Hold
10
﹤0.01% 381
2021
Q3
$3K Hold
10
﹤0.01% 384
2021
Q2
$3K Hold
10
﹤0.01% 375
2021
Q1
$3K Hold
10
﹤0.01% 375
2020
Q4
$3K Hold
10
﹤0.01% 356
2020
Q3
$3K Hold
10
﹤0.01% 314
2020
Q2
$3K Hold
10
﹤0.01% 319
2020
Q1
$1K Hold
10
﹤0.01% 335
2019
Q4
$2K Hold
10
﹤0.01% 333
2019
Q3
$2K Hold
10
﹤0.01% 339
2019
Q2
$3K Buy
+10
New +$2.65K ﹤0.01% 336

Other funds holding ABMD

Adirondack Trust Company's ABMD Position: Q4 2022 in Review

Adirondack Trust Company sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 10 shares — an estimated $2K sold.

Adirondack Trust Company first reported a position in ABMD in Q2 2019 and held it in 14 quarters. The position peaked at $4K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Adirondack Trust Company reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Adirondack Trust Company sold 10 Abiomed Inc shares in Q4 2022, an estimated $2K.
  • Adirondack Trust Company first reported a position in Abiomed Inc in Q2 2019 and held it in 14 quarters.
  • Adirondack Trust Company's Abiomed Inc position peaked at $4K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Adirondack Trust Company's 13F filing for Q4 2022, filed 13 Jan 2023.